Lipocine (NASDAQ: LPCN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.
The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 314.20% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lipocine (NASDAQ: LPCN) is $0.845 last updated Today at June 28, 2022, 2:46 PM UTC.
There are no upcoming dividends for Lipocine.
Lipocine’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.